Pandemic launch woes: Esperion cuts 40% of workforce, goes all in on cholesterol drug's outcomes trial
18th October 2021 Uncategorised 0 Pandemic launch woes: Esperion cuts 40% of workforce, goes all in on cholesterol drug’s outcomes trial
aliu
Mon, 10/18/2021 – 10:35
More: Pandemic launch woes: Esperion cuts 40% of workforce, goes all in on cholesterol drug's outcomes trial
Source: fierce